1 / 15

Incidence & Predictors of Treatment Failure for Bacterial Vaginosis

Incidence & Predictors of Treatment Failure for Bacterial Vaginosis. JM Marrazzo , KK Thomas, K Ringwood, T Fiedler, DN Fredricks University of Washington & Fred Hutchinson Cancer Research Center, Seattle WA jmm2@u.washington.edu. Background. Most common

thuy
Download Presentation

Incidence & Predictors of Treatment Failure for Bacterial Vaginosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Incidence & Predictors of Treatment Failure for Bacterial Vaginosis JM Marrazzo, KK Thomas, K Ringwood, T Fiedler, DN Fredricks University of Washington & Fred Hutchinson Cancer Research Center, Seattle WA jmm2@u.washington.edu

  2. Background • Most common • Cause of vaginal symptoms prompting medical evaluation for vaginitis • Cause of vaginitis • >10% of women experience BV • May cause 11% of preterm deliveries in U.S. • Etiology not understood, but associated with douching, new male partner, unprotected sex in heterosexual women, sex between women • Frequently persists after treatment (15% - 20%) • Very frequently recurs after successful treatment (30% - 60%) • History of BV, regular partner throughout follow-up, and female partner implicated Sobel 2006; Bradshaw 2006

  3. Background • Traditionally defined asovergrowth of commensal anaerobic flora (classically G. vaginalis, Prevotella, Mobiluncus, M. hominis) relative to H2O2+ lactobacilli • Molecular (cultivation-independent) approaches have recently expanded spectrum of BV microbiology • Some bacteria highly specific for BV in recent studies • Some with known high-level resistance to metronidazole • Atopobium vaginae • “New” bacteria not yet incorporated into prospective analyses for BV persistence or recurrence Verstraelen 2004, Ferris 2004, Fredricks 2005

  4. BV-associated bacteria (BVAB 1, 2, 3) and their relationship to bacteria in the Clostridium phylum BVAB1 Clostridium Cluster XIVa BVAB3 BVAB2

  5. Methods • Subjects recruited to research clinic • 16-29 years • Sex with woman (prior year) • Recruited through ads (self-referred) and partners • Underwent computer-assisted self-interview (CASI) at enrollment • BV diagnosed by Amsel criteria and treated with vaginal metronidazole • BV confirmed by Nugent criteria (later) • Vaginal fluid collected with polyurethane foam swab and saline lavage (0.5 cc)

  6. Methods • All women with BV asked to return at 1 month for repeat procedures (CASI, vaginal fluid collection) • BV persistence = Nugent >6 • Abnormal vaginal flora = Nugent >3 • All women asked to return at 3 months • BV recurrence defined by Nugent score >6 among women whose baseline BV was cured at 1 month

  7. Methods Vaginal Fluid Collected at All Visits: • Traditional culture • Used to define H2O2 production by lactobacilli • Typical panel of anaerobic flora • Bacterium-specific PCR assays based on cloned 16s rDNA sequences derived from earlier analysis of clones by RFLP, sequencing; all positive results sequence-confirmed

  8. Characteristics: Median age 25 y Nonwhite: 25% Sex with male last 3 mos: 28% Douche last 3 mos: 6.4% BV N = 12 / 72 (17%) BV @ baseline N = 66 (28%) No BV N = 173 (72%) New BV during study N = 6 239 women enrolled No BV N = 60 / 72 (83%) ResultsBaseline and Persistent BV + At 1 month 72 women with BV • 28% had BV at baseline • Overall f/u at 1 month = 90% • 83% responded to vaginal MTZ • Persistent BV incidence: 17%

  9. ResultsFactors Associated with BV Persistence Demographics Incidence of BV Recurrence (%) OR (95% CI) Age 26-33 y 3.9 (0.9, 16.4) Black race 7.0 (3.9, 12.4) P=0.03 P=0.06 Baseline Vaginal Microbiology (PCRs) OR (95% CI) BVAB1 2.3 (0.8, 6.5)) BVAB2 2.2 (0.3, 15.5) BVAB3 4.4 (1.5, 13.4) P=0.009 P=0.15 P=0.67

  10. ResultsAdditionalFactors Associated with Persistence of Abnormal Flora (N = 22) Incidence of BV Recurrence (%) P=0.05 P=0.05 P=0.02 P=0.09 OR (95% CI) BVAB1 2.6 (1.3, 5.2) Adherence 0.36 (0.2, 0.7) Any sex 4.1 (0.6, 28) Vaginal sex 2.1 (1.1, 4.2) *Intercourse with male partner

  11. BV N = 12 / 72 (17%) BV @ baseline N = 66 (28%) No BV N = 173 (72%) New BV during study N = 6 239 women enrolled No BV N = 60 / 72 (83%) Recurrent BV N = 8 / 53 (15%) ResultsBaseline and Persistent BV + At 1 month 72 women with BV • 15% who initially responded to MTZ had BV recurrence

  12. Conclusions • Distinct risks predict BV persistence • Demographics • Black women consistently at high risk for BV • Reasons unclear; not related to douching in our study • Older age • Vaginal microbiology • BVAB3, possibly BVAB1 • Sex • Vaginal fluid exchange, intercourse with men [Sanchez 2004, Bradshaw 2006] • Further study needed • Additional accrual of subjects to substantiate preliminary trends and assess risks for BV recurrence • Cultivation of BVAB to assess pathogenicity and antibiotic susceptibilities

  13. Limitations • Small number of subjects who were self-referred or referred by partners • Limits on reproducibility, generalizability • However, excellent retention and diverse sexual practices • Development of bacterium-specific PCRs directed by initial clone analysis • May not include all relevant species

  14. Study personnel Nancy Dorn Dana Varon Lauren Asaba Susan Heideke Corey Fish Kathy Agnew Becca Hutcheson Acknowledgements Support • Dave Eschenbach • Sharon Hillier • King Holmes • Larry Corey

  15. Associations Between Bacteria Detected and BV Bacterium-specific PCR assays for vaginal fluid samples from 40 subjects with BV and 65 without BV. ORs adjusted for age, site of enrollment, vaginal symptoms, report of sex with men

More Related